神经免疫相互作用:过去的经验如何影响现在和未来的MS护理
Adil Harroud1,2,3, Jack P Antel1,2
1The Neuro (Montreal Neurological Institute-Hospital), Montréal, QC, Canada.
概括
在多发性硬化症 (MS) 发病过程中,神经免疫相互作用至关重要. 本综述探讨了免疫系统和中枢神经系统如何相互影响,影响多发性硬化症的进展和治疗.
科学领域:
- 神经免疫学
- 中枢神经系统 (CNS) 疾病
- 多发性硬化 (MS) 的发病
背景情况:
- 人们越来越认识到神经免疫相互作用在多发性硬化症 (MS) 中的作用.
- 了解免疫系统和中枢神经系统之间的相互作用对于MS研究至关重要.
- 这些相互作用的复杂性影响了疾病的发展和治疗策略.
研究的目的:
- 在MS的背景下审查免疫系统和中枢神经系统之间的双向通信.
- 突出影响神经免疫动态的关键因素,包括病变区分,衰老和并发症.
- 探索质细胞和免疫细胞在中枢神经系统损伤和修复中的作用.
主要方法:
- 综合实验模型和临床观察的文献审查.
- 分析系统免疫和中枢神经系统之间的双向信号通路.
- 检查细胞 (质细胞和免疫细胞) 对MS病理和恢复的贡献.
主要成果:
- 神经免疫相互作用显著影响多发性硬化症的发病和疾病进展.
- 系统性免疫活动可以启动或修改中枢神经系统病理,而中枢神经系统信号可以塑造外周免疫力.
- 质细胞和免疫细胞在损伤和促进修复过程中起着双重作用.
结论:
- 神经免疫相互作用的双向性是理解和治疗多发性硬化症的核心.
- 诸如衰老和并发症等因素会影响这些相互作用,影响疾病的结果.
- 对神经免疫力学的洞察对于开发MS和相关神经疾病的先进治疗方法至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The Blood-brain Barrier
48.6K
Overview
48.6K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K


